These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29626777)

  • 61. The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017.
    Kurtz SP; Buttram ME; Margolin ZR; Wogenstahl K
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):700-706. PubMed ID: 30909323
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses.
    Bi-Mohammed Z; Wright NM; Hearty P; King N; Gavin H
    Drug Alcohol Depend; 2017 Feb; 171():122-131. PubMed ID: 28086177
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Abuse of Pharmaceutical Drugs and Its Prevention.
    Meng SQ; Shi J
    Fa Yi Xue Za Zhi; 2021 Dec; 37(6):788-795. PubMed ID: 35243843
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The use of abusable prescription drugs: the role of gender.
    Simoni-Wastila L
    J Womens Health Gend Based Med; 2000 Apr; 9(3):289-97. PubMed ID: 10787224
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Psychosocial interventions for chronic pain and comorbid prescription opioid use disorders: A narrative review of the literature.
    Hruschak V; Cochran G; Wasan AD
    J Opioid Manag; 2018; 14(5):345-358. PubMed ID: 30387858
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Non-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use.
    Lucke J; Jensen C; Dunn M; Chan G; Forlini C; Kaye S; Partridge B; Farrell M; Racine E; Hall W
    BMC Public Health; 2018 Nov; 18(1):1270. PubMed ID: 30453936
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nonmedical use of prescription medications in young adults.
    Tapscott BE; Schepis TS
    Adolesc Med State Art Rev; 2013 Dec; 24(3):597-610. PubMed ID: 24654550
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert Program.
    Piper BJ; Desrosiers CE; Fisher HC; McCall KL; Nichols SD
    Pharmacotherapy; 2017 Jul; 37(7):791-798. PubMed ID: 28543168
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice.
    Binswanger IA; Glanz JM
    Subst Abus; 2015; 36(2):141-3. PubMed ID: 25671706
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Machine Learning Approach for the Detection and Characterization of Illicit Drug Dealers on Instagram: Model Evaluation Study.
    Li J; Xu Q; Shah N; Mackey TK
    J Med Internet Res; 2019 Jun; 21(6):e13803. PubMed ID: 31199298
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Misuse of Methylphenidate.
    Clemow DB
    Curr Top Behav Neurosci; 2017; 34():99-124. PubMed ID: 26695166
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prescription drug diversion, misuse, and abuse among people living with HIV: a scoping review protocol.
    Chibi B; Torres NF; Mashamba-Thompson TP
    Syst Rev; 2020 Feb; 9(1):29. PubMed ID: 32051029
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patterns of prescription drug misuse presenting to provincial drug clinics.
    Robinson G; Judson G; Loan R; Bevin T; O'Connor P
    N Z Med J; 2011 Jun; 124(1336):62-7. PubMed ID: 21946745
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.
    Severtson SG; Ellis MS; Kurtz SP; Rosenblum A; Cicero TJ; Parrino MW; Gilbert MK; Buttram ME; Dasgupta N; BucherBartelson B; Green JL; Dart RC
    Drug Alcohol Depend; 2016 Nov; 168():219-229. PubMed ID: 27716575
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of Stigma.
    Allen B; Harocopos A
    J Subst Abuse Treat; 2016 Nov; 70():81-86. PubMed ID: 27692193
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Managing prescription drug diversion risks: caring for individuals at home.
    Pancari J; Baird C
    J Addict Nurs; 2014; 25(3):114-21. PubMed ID: 25202807
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Non-medical use of prescription drugs and HIV risk behaviour in transgender women in the Mid-Atlantic region of the United States.
    Benotsch EG; Zimmerman RS; Cathers L; Pierce J; McNulty S; Heck T; Perrin PB; Snipes DJ
    Int J STD AIDS; 2016 Aug; 27(9):776-82. PubMed ID: 26185044
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antiretroviral medication: an emerging category of prescription drug misuse.
    Davis GP; Surratt HL; Levin FR; Blanco C
    Am J Addict; 2014; 23(6):519-25. PubMed ID: 24102874
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary prevention of prescription opioid diversion: a systematic review of medication disposal interventions.
    Schäfer WLA; Johnson JK; Wafford QE; Plummer SG; Stulberg JJ
    Am J Drug Alcohol Abuse; 2021 Sep; 47(5):548-558. PubMed ID: 34292095
    [No Abstract]   [Full Text] [Related]  

  • 80. [The German Cardiovascular Disease Prevention Study: social gradient in use of drugs with a potentially addictive nature. An analysis of selected indications groups].
    Breckenkamp J; Laaser U
    Med Klin (Munich); 1999 Jun; 94(6):306-13. PubMed ID: 10420722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.